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Abstract 
Background: Advances in viral sequence analysis make it pos-
sible to track the spread of infectious pathogens, such as HIV,
within a population. When used to study HIV, these analyses (i.e.,
molecular epidemiology) potentially allow inference of the identi-
ty of individual research subjects. Current privacy standards are
likely insufficient for this type of public health research. To
address this challenge, it will be important to understand how
stakeholders feel about the benefits and risks of such research. 
Design and Methods: To better understand perceived benefits
and risks of these research methods, in-depth qualitative inter-
views were conducted with HIV-infected individuals, individuals
at high-risk for contracting HIV, and professionals in HIV care and
prevention. To gather additional perspectives, attendees to a public
lecture on molecular epidemiology were asked to complete an
informal questionnaire. 
Results: Among those interviewed and polled, there was near
unanimous support for using molecular epidemiology to study
HIV. Questionnaires showed strong agreement about benefits of
molecular epidemiology, but diverse attitudes regarding risks.
Interviewees acknowledged several risks, including privacy
breaches and provocation of anti-gay sentiment. The interviews
also demonstrated a possibility that misunderstandings about
molecular epidemiology may affect how risks and benefits are
evaluated.
Conclusions: While nearly all study participants agree that the
benefits of HIV molecular epidemiology outweigh the risks, con-
cerns about privacy must be addressed to ensure continued trust in
research institutions and willingness to participate in research.
Introduction
Despite rapid advances in treatment and prevention of HIV,
rates of new infections remain unacceptably high.1,2 Targeting
limited resources to the highest risk individuals and groups (social
networks) remains a major challenge of prevention efforts.
Molecular epidemiology (ME) offers an approach to understand
patterns of transmission. ME takes advantage of the fact that many
RNA viruses, like HIV, evolve at a rapid pace.3 This leads to the
development of significant viral diversity within infected individ-
uals, and across populations over time. A virus transmitted recent-
ly from one person to several others will result in a cluster (net-
work) of individuals with more closely related viruses. Thus, viral
sequence relationships within the HIV infected population can be
exploited using ME to not only reconstruct the evolutionary histo-
ry of the virus but to infer patterns of transmission within a sam-
pled population. On a local level, aggregation and integration of
molecular, clinical and demographic data offers a unique opportu-
nity to better understand the dynamics of local transmission net-
works.4-6 Inferences made on the spread of HIV in a local sub-epi-
demic could then potentially be used to identify key sub-popula-
tions with high rates of transmission to better target prevention
and treatment resources. For example, HIV ME has been used to
identify sociodemographic and geographic hotspots of HIV trans-
mission.7
Molecular epidemiology is a powerful tool in the study of
infectious diseases, but is little known outside the scientific com-
munities that use it. When applied to the study of HIV transmis-
sion ME can provide researchers with important insights into the
spread of HIV and also identify methods to interrupt this spread.
However, this technique also has the potential to generate
extremely sensitive information and allow inference of the identi-
ty of individual participants, presenting unique challenges for
maintaining privacy for research participants while maximizing
the utility of the information produced. Without sufficient protec-
tions, ME data could, for example, be used to implicate individual
research participants in the spread of HIV.8,9
The more information collected about an individual, the easier
it is to deduce the identity of that person without relying on tradi-
tional categories of identifying information such as name, address,
or social security number. This was demonstrated by Gymrek et
al.10 in a 2013 study, where public databases were used to triangu-
late the identifiers of participants in public sequencing projects,
enabling identification of some individuals who participated. In
the context of HIV ME research, most scientific journals require
that the analysed sequence data be published, information that
may be unique to each individual. Coupled with the fact that the
study populations are often small, these factors can significantly
increase the risk of identification,11 and may suggest, but never
Significance for public health
When molecular epidemiology is used to study HIV, it can demonstrate how
HIV infections are related and how to target prevention efforts. Applying
these analyses for maximal benefit in the fight against HIV would almost cer-
tainly make individuals whose data are analyzed vulnerable to discovery.
However, absolute protection of this sensitive information would require
that research into these methods not be done. The success of HIV molecular
epidemiology will depend on finding a balance between public health and the
interests of individuals living with HIV. The stakeholders interviewed in this
study agreed that molecular epidemiology should be used to study HIV epi-
demics and transmission despite risks to privacy. However, these interviews
also highlighted the difficulty of understanding molecular epidemiology and
its privacy implications. For HIV molecular epidemiology to continue, privacy
protections must go beyond simply masking traditional identifiers and
assuming participants are informed enough to consent to the risks. 
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definitively prove, possible sources of transmission.8,9
Furthermore, this information may be used by public health depart-
ments in outbreak investigations, and the published reports of these
investigations, even when devoid of protected health information,
may still provide clues to the identities of individuals involved.12
With respect to the analyses of HIV genetic data to infer transmis-
sion patterns, the stakes are higher as 33 states in the US have laws
that criminalize the transmission of HIV.13,14 Identification of an
individual in an HIV transmission network could suggest, although
not prove, high risk behaviour such as sharing needles or sex with
a large number of partners. Though these data do not exclude the
presence of one or more un-sampled infected individuals in the
transmission chain, genetic similarities between infections may be
misinterpreted as evidence of direct contact with other individuals.
Because HIV ME data could implicate an individual in the trans-
mission of HIV, a breach of privacy could result in devastating per-
sonal and legal consequences. 
HIV ME researchers must protect personal privacy if they are
to maintain trust with the populations they study. They must strike
a balance that reasonably protects individuals’ privacy, but still
allows them to report meaningful scientific findings and bring the
power of HIV ME to the fight against HIV. The right balance will
honour the interests of the research subjects, the researchers, pro-
fessionals in HIV care and prevention, and the public. However,
determining these interests is difficult when so few people have
adequate knowledge and understanding of how molecular epi-
demiology works. To meet these challenges, we previously pro-
posed a strategy for handling data generated by HIV ME using
techniques that allow formal quantitative tradeoff between privacy
and accuracy of information extracted from the data.11 The success
of such techniques requires making tradeoffs among the complex
interests of researchers, research participants, HIV care providers,
and the public. This study is a first attempt to assess how an opti-
mal tradeoff might be found by asking how stakeholders weigh the
benefits and risks involved in HIV ME. We conducted in-depth
qualitative interviews with individuals living with HIV, individuals
at risk for acquiring HIV, and professionals working in HIV care
and prevention. We also distributed an informal questionnaire to
the audience of a public lecture on the topic of HIV ME. In this
paper, we discuss how our research participants responded to an
explanation of HIV ME, the risks they anticipated and reported
being most concerned about, and the common misunderstandings
of HIV ME revealed in the interviews. 
Materials and MethodsEthical approval
All procedures performed in studies involving human partici-
pants were in accordance with the ethical standards of the
University of California San Diego Human Research Protections
program (UCSD HRPP). Informed consent was obtained from all
individual participants included in the study, except where a waiv-
er of consent for anonymous questionnaires was obtained from the
UCSD HRPP.Interviews 
Qualitative interviews were conducted with forty individuals
over six months beginning in February of 2015. Four categories of
stakeholders were recruited: HIV infected individuals (n=11) and
HIV uninfected but at-risk individuals (n=10), medical profession-
als (doctors and nurses working with HIV patients) (n=11), and
non-medical professionals working in HIV prevention and care
(i.e. activists, non-profit administrators, epidemiologists) (n=8).
Interviewees were recruited through the research and professional
networks of SL and SM in and around San Diego, California.
Many HIV positive and HIV at risk recruits were concurrently
enrolled in on-going HIV prevention studies. Table 1 summarizes
demographic characteristics of the four groups. 
Two versions of an interview guide were piloted and revised
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Table 1. Demographic summary of groups interviewed.
                                                      HIV+        At risk for HIV infection        Medical professional           Non-medical professional       All
Number                                                             11                                      10                                                        11                                                              8                                    40
Gender                                                                                                                                                                                                                                                                              
       Men                                                             9                                       10                                                         7                                                               2                                    28
       Women                                                       2                                        0                                                          4                                                               6                                    12
Sexuality                                                                                                                                                                                                                                                                           
       Men who have sex with men                 7                                       10                                                         4                                                               2                                    23
       Heterosexual                                            4                                        0                                                          0                                                               0                                     4
       Sexuality not reported                            0                                        0                                                          7                                                               6                                    13
Average age                                                      43                                      36                                                        43                                                             47                                 42.25
Age range                                                       23-65                                22-57                                                  31-64                                                        28-68                              22-68
History of injection drug use                        4                                        0                                                  Not asked                                               Not asked                             4
Race/Ethnicity                                                                                                                                                                                                                                                                  
       White                                                          3                                        5                                                          7                                                               5                                    20
       African American                                     2                                        1                                                          1                                                               0                                     4
       Latino                                                         6                                        3                                                          1                                                               3                                    13
       Declined to answer                                 0                                        1                                                          0                                                               0                                     1
Education                                                                                                                                                                                                                                                                          
       Less than HS diploma                             3                                        1                                                          0                                                               0                                     4
       High school only                                       2                                        0                                                          0                                                               0                                     2
       Some college                                            4                                        2                                                          0                                                               0                                     6
       Bachelor's Degree                                  2                                        5                                                          0                                                               4                                    11
       Some postgraduate                                 0                                        2                                                          0                                                               0                                     2
       Postgraduate                                             0                                        0                                                        11*                                                             4                                    15
*3 Registered Nurses, 8 Medical Doctors.
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before conducting the first interview. Pilot interviews were con-
ducted with staff serving as mock interviewees. Each in-depth
semi-structured interview lasted approximately one hour. All inter-
views were conducted by CS, a Ph.D. sociologist specializing in
qualitative interviewing and observed by one other team member.
CS had no formal training in molecular epidemiology or HIV pre-
vention. Each interview followed a course unique to the intervie-
wee, not all questions were asked of all respondents and some
explanations and prompts were modified as we discovered the
most effective wording. 
All interviews were structured to move from a general expla-
nation of molecular epidemiology to increasingly specific inquiries
about potential privacy concerns. After collecting demographic
information from the interviewee, the interviewer gave a basic
explanation of molecular epidemiology (see Supplemental
Material) using a mockup of an HIV transmission network map
(Figure 1). This explanation was carefully crafted based on our
experience in the public forum and with input from our team. CS
also presented it to all professional interviewees and asked directly
if they would change or add to it. As feedback was positive, the
explanation was not substantially changed during the interviewing
phase of the study. 
After explaining HIV ME, the interviewer initiated a general
discussion of questions and ideas offered by the interviewee about
this explanation. Interviewees were then asked about various hypo-
thetical scenarios illustrating ethical dilemmas related to molecular
epidemiology. These scenarios were open-ended as they presented
ethical dilemmas that have no determined resolution. For example,
one scenario described a researcher identifying an outbreak of HIV
at a university using HIV ME and asked the interviewee, Do you
think the researchers would have an ethical obligation to act on
this information? If so, what could they do?
The interviews offered many opportunities to explore stake-
holders’ understanding of and attitudes toward the potential risks
of HIV ME. Most interviewees were asked about potential risks
twice during the interview. After the initial explanation of HIV
ME, they were asked to respond to open questions such as, What
are your thoughts? or What do you think people could do with this?
Some respondents immediately began to express concerns. In early
interviews, some who did not raise concerns spontaneously were
not asked about risks specifically. As the interview guide was
refined, we began to ask specifically, Are there any risks to doing
this research that come to mind? At the conclusion of the inter-
view, respondents were again asked about the risks: Of all the risks
we have discussed today or any others you can think of, what is the
most worrisome to you? We compared these two points in the inter-
view to examine both first impressions after presentation of the
approach and the effect of the in depth discussion and presentation
of scenarios on these attitudes. Finally, we asked interviewees if
the benefits of HIV ME outweigh the risks.Analysis of interview data 
Interviews were audio recorded and transcribed. In addition,
CS prepared brief summaries from her field notes. Transcripts
were coded in Atlas.ti.15 with a grounded theory approach,16-18
using a combination of question-specific codes and codes devel-
oped from the themes that emerged across interviews. Codes were
identified and codified by CS and MK. Transcripts were coded by
either CS or MK. The coded content discussed in this article was
again reviewed by CS at the time of writing. Public forum questionnaires
The authors began this project with the conviction that deter-
mining ethical standards for the use of HIV ME should include
people who are not engaged in developing the technology. To this
end, the project included a set of public forums in which HIV ME
was introduced and discussed. The first of these forums was held
during the development of the interview guide (two weeks before
the initial interview) and informed our approach to presenting the
benefits and risks of the technique. Alongside our qualitative find-
ings, we present some of what we learned from informal question-
naires given to attendees of the public forum on HIV ME. These
questionnaires captured opinions of more individuals about the
risks and benefits of HIV ME, but are not intended as a definitive
measure of the general public’s opinion. 
The Exploring Ethics forum is a regular series organized by
San Diego’s Reuben H. Fleet Science Center and the Center for
Ethics in Science and Technology. The forum on HIV Molecular
Epidemiology began with a 20-minute presentation about HIV ME
describing the method, suggested applications, and possible risks
of the approach. Informal questionnaires were distributed to atten-
dees after the talk, and before the question and answer portion of
the program. All answers were collected anonymously and a waiv-
er of consent for these questionnaires was obtained from the UC
San Diego Human Research Protections program. One question-
naire in which the respondent indicated he or she was less than 18
years old was discarded. 
The lecture presented the primary benefits of HIV ME as relat-
ed to public health and research, and the questionnaire asked atten-
dees to respond to these benefits and potential risks. Attendees
were asked to evaluate four potentially positive outcomes of HIV
ME and four potentially negative outcomes, or risks of HIV, and
rate the strength of these potential benefits and risks for popula-
tions studied with HIV ME. They were also asked to respond to the
question if participants are adequately informed of risks and agree
to participate, should [HIV ME research] be done?
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Figure 1. Sample Network Diagram used in interview to illustrate
how molecular epidemiology works. Each oval represents an HIV
infected individual. Grey lines represent putative linkages
between individuals with genetically similar HIV sequences.
Colours may represent any demographic variable, for example,
zip code, HIV risk factor or ethnicity.
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ResultsSupport for molecular epidemiology
There was general support for molecular epidemiology among
the public forum attendees. After rating the benefits and risks of
HIV ME, 50 of 53 attendees answered that the research should be
done because the potential benefits to public health outweigh risks
to individual participants. One attendee was unsure and two failed
to answer this item.
Most interviewees also expressed support for the use of HIV
ME. At the conclusion of each interview, when respondents were
asked if the benefits of HIV ME outweigh the risks, all said yes.
Three-quarters of respondents answered with an unqualified,
emphatic, or even enthusiastic, yes, to the concluding question.
The other quarter of respondents gave a positive answer with qual-
ifications, such as It’s very necessary, just as long as parameters
are set in place and they’re kept (#161), or, With proper protections
in place, the benefits outweigh the risks (#386). Figure 2 shows the
two types of answers by subject group. Of the 10 answers with
caveats, 1 came from an HIV positive respondent, 2 from HIV at
risk respondents, 3 from medical professionals, and 4 from non-
medical professionals. Benefits and risks
Questionnaire responses collected at the public forum suggest-
ed general agreement about benefits of HIV ME, but more diversi-
ty in responses about risks. The interviews, then, gave us a chance
to explore the types of risks interviewees could anticipate and how
they responded to these risks. 
Comparing basic descriptive statistics of the questionnaire
answers illustrates the trend among the public forum attendees.
Table 2 presents the means and standard deviations for the ratings
of each listed benefit and Table 3 presents the means and standard
deviations for the rating of each listed risk. The listed benefits
received a mean rating of 4.6 (5 being very valuable), while the
risks listed on the questionnaire received a mean rating of 3.0 (5
being very worrisome). Comparison of the standard deviations
show that the distribution of answers regarding benefits was far
more uniform than that of the risks. Figures 3 and 4 show the fre-
quencies of ratings for each type of benefit and risk. Nearly all
questionnaire respondents rated the benefits neutrally or positively,
while responses to the risks were more evenly distributed between
not concerned and very concerned, creating a near neutral mean. 
Most interviewees were asked specifically about risks and ben-
efits twice; first after the initial explanation of HIV ME and the
again at the conclusion of the interview. The range of risks voiced
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Table 2. Mean ratings of the value of benefits of HIV transmission research by attendees to public forum.
In your opinion, how valuable are the following potential benefits of HIV Network Research?                          Mean                   Std. 
(1=Not Valuable, 5=Very Valuable)                                                                                                                                                    Deviation
Improved understanding of HIV transmission                                                                                                                                                               4.7                             0.56
Improved public education about HIV transmission                                                                                                                                                    4.4                             0.82
Interventions (testing or education) tailored to a particular group                                                                                                                        4.6                             0.69
Treatment of individuals identified as high-risk                                                                                                                                                            4.7                             0.57
Table 3. Mean ratings of concern over risks of HIV transmission research by attendees to public forum.
How concerned are you about the following potential risks of HIV Network Research?                                      Mean                   Std. 
(1=Not Concerned, 5=Very Concerned)                                                                                                                                             Deviation
Personal health information gets lost or stolen                                                                                                                                                           3.0                             1.18
Personal health information becomes publicly accessible                                                                                                                                        3.4                             1.35
Easier for others to guess an individual’s HIV status                                                                                                                                                  3.0                             1.29
Research reveals who may have been the source of an HIV infection                                                                                                                    2.7                             1.43
Figure 2. Responses by subject group to final interview question:
Given the benefits and risks we just talked about, do you think
the benefits outweigh the risks?
Figure 3. Frequencies of questionnaire responses rating value of
potential benefits of HIV ME. 1 = Not Valuable; 5 = Very
Valuable.
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early in the interviews suggest, like the questionnaire answers,
how little consensus there may be among the casually informed
regarding the risks of HIV ME.Initial concerns
Most interviewees identified potential risks or concerns at the
start of the interview, whether spontaneously or prompted. The
issues they raised related to a) privacy, b) public response to HIV
ME, c) potential setbacks that might be faced by the research team
(usually in recruiting subjects), and d) other concerns such as psy-
chological damage to subjects. Each of these categories is
described below. Figure 5 illustrates how these categories of con-
cern were distributed across groups. Privacy 
About one quarter of interviewees anticipated some privacy
concern early in the interview, either saying that they would be
concerned or that they felt others would be concerned. Some
respondents spoke about potential dangers of being able to single
out individuals based on their position in an HIV transmission net-
work. Others raised the possibility of research subjects finding out
new information about each other. A physician mentioned that
inadvertent disclosure of a particular set of relationships could
raise questions of infidelity, or un-closeting someone who didn’t
wish that, that would be a potential issue. (#469) An HIV+ inter-
viewee said, It’s more of a privacy issue for myself as well. I hon-
estly wouldn’t want to know who gave it to me, how I got it or what-
not, just due to the fact that even if I did know, there’s nothing I
could really do about it no more. (#183) An HIV at risk respondent
mused: 
If [subjects] talk amongst themselves they could very well con-
clude that maybe they’re all part of a same group or that others
amongst themselves – if they are in fact friends that someone else
is infected or that there’s a common source, or we could get into
something, infidelity, where there’s maybe just the one cheating
boyfriend who’s bouncing around… So that’s one risk I suppose,
losing anonymity within the research program itself. (#215)
A non-medical professional who handles epidemiological data
talked about how, when the population is large enough, it would be
difficult to identify any one subject, but when reporting on a small-
er or more rural population, researchers need to be more careful.
This professional explained that if their team is examining a race-
ethnicity that’s unusual for that area or a risk group that’s less
usual for that area, some of those things set off alarms for us.
(#350) This professional interviewee drew a parallel between HIV
ME and other epidemiology studies that may divide the population
in question into small enough groups that individual identity might
be guessed.Public response
Concerns about public response to HIV ME were primarily
about the findings being used to promote anti-gay sentiment,
potentially threatening hard-won gay rights. One HIV positive
respondent worried, Probably going to have a couple, three hate
crimes or… tagging the walls about graffiti and bad stuff about
people that are gay (#141). An HIV at risk respondent said, I think
if that information got out, I think that would just add fuel to the
fire in certain ways… This epidemiology that you’ll be able to do
will really bring a light to how promiscuous at least gay men are
and bisexual men too that are married to women. (#212) When
asked, at that early point in the interview, if he thought the risks
outweighed the benefits, this respondent said, You know the sad
thing is, yeah, I think you’re about 20 years too soon. (#212) A
non-medical professional echoed this concern, I can imagine it
coming up in political campaigns. In a time where the Supreme
Court just ruled on marriage equality, someone looking at this and
using it as evidence that this whole gay community is out of con-
trol. (#348)Research setbacks
Some respondents saw issues of privacy primarily as a prob-
lem for the integrity of the research, rather than a true risk to sub-
jects. While these answers focused on privacy, they did not indi-
cate that the respondent understood the particular privacy concerns
that are specific to ME. These answers often focused on how the
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Figure 4. Frequency of questionnaire responses rating concern
over potential risks of HIV ME. 1 = Not Concerned; 5 = Very
Concerned.
Figure 5. Concerns raised early in the interview, after the first
explanation of molecular epidemiology, by subject group.
Figure 6. Concerns identified as most worrisome at conclusion of
interview, by subject group.
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privacy concerns of potential subjects might make it difficult to
recruit for the study or skew findings. An HIV at risk respondent
said, Someone who likes to hold on to their social status, who likes
to be flirted with, who likes to hook up with guys, they will keep
that information private, so they won’t contribute to this. (#252)
Another HIV at risk respondent said, the only downside would be,
are people withholding honest answers because of their fear of pri-
vacy?. (#263) A physician spoke at length about the problems of
recruiting in rural communities, concluding, That is where you are
going to get biases in… that you are probably, [recruiting] people
who are at least comfortable with their sexuality or/and their HIV
status. (#457)Other concerns
Some initial concerns focused on possible dangers to subjects.
For example, an HIV positive respondent wondered if the
researchers would be held responsible if a person doesn’t take the
information in a mentally well-adjusted way, and then they go and
commit a crime. (#145) Another HIV positive respondent was con-
cerned that simply being in a study related to HIV shortly after
being diagnosed “would be scary” because it would push them to
come to terms that they are HIV-positive (#105). Other intervie-
wees worried about the potential of HIV ME to identify who
infected whom. Such concerns focused on how fear of accusations
and legal action may create resistance to the research.Final concerns
Although initial concerns were diverse, by the end of the inter-
view most felt that privacy was the most worrisome risk related to
the technique. Figure 6 shows the final concerns raised by each
subject group. Answers were not mutually exclusive as some
respondents raised more than one concern or raised a concern that
was mitigated by their trust in the research process. At the end,
nearly three-quarters of interviewees discussed some aspect of pri-
vacy. Some spoke generally about a loss of confidentiality, while
others described more specifically the consequences of such a
breach, usually either focusing on interpersonal problems arising
from one’s HIV status being disclosed, or on possible sources of
discrimination based on disclosed HIV status. Only 6 of the indi-
viduals who concluded with privacy concerns had named privacy
as a potential risk at the beginning of the interview. Seven respon-
dents concluded the interview citing concerns about the public
response to HIV ME as most worrisome, including 4 respondents
who had anticipated privacy concerns at the outset. Finally, three
HIV positive respondents said they had no concerns while
acknowledging that privacy might be a concern for others. Common misunderstandings
While there was overwhelming support for molecular epidemi-
ology of HIV, there were some common misunderstandings about
HIV ME among respondents. Both professional and lay respon-
dents demonstrated similar confusion with some specific aspects
of HIV ME. 
One set of misunderstandings stemmed from difficulty in
grasping the rapid mutation and evolution of HIV that provides the
phylogenetic signal to infer relationships between sequences. This
often resulted in a failure to understand why the sequences and
their relationships could potentially generate genetically identifi-
able information. Such confusion made it difficult for some
respondents to appreciate the sensitivity of the information created
by molecular epidemiology, specifically that an individual could
be identified as part of an outbreak.
Another set of misunderstandings cantered on the interpreta-
tion of the sample network diagram (Figure 1). Many had difficul-
ty understanding what was represented by the grey lines (edges)
connecting two individuals (nodes). The interviewer always
explained that “the dots that are connected with lines are viruses
that are closely related. This means that they are less than 1.5%
genetically different. Unrelated infections could be up to 20% dif-
ferent.” Nevertheless, many respondents persisted in assuming that
these lines indicated a confirmed or reported encounter between
the individuals. One subject focused on the colours of the nodes,
which represented geographic location, and did not seem to appre-
ciate that the diagram showed more than this information. Other
subjects incorrectly inferred directionality of infection despite
efforts to underscore that the diagram did not show this, and that,
furthermore, all links were only putative. In some cases, misread-
ing of the diagram appeared to convince interviewees that the tech-
nique has more power than it does (i.e. it could show who gave me
HIV) or support a sense of complacency (i.e. don’t we already
know this?).
Some respondents appeared to have the impression that HIV
ME could determine if a specific undiagnosed individual had been
exposed to or acquired HIV. For example, an HIV positive respon-
dent said, So, for me, [the benefit is] to call a person and to let
them know what they have and all that in a way it’s to save their
lives. Because if you don’t, down the road, you know, they might get
sick to a point where there’s nothing you’re gonna be able to do
(#172). This quote describes a scenario where researchers are able
to contact a particular person who has not been tested for HIV to
let them know that they are infected. Similarly, another respondent
felt that the only benefit of the technique would be to discover peo-
ple who are high risk and HIV negative. These misunderstandings
overestimate the power of the technique. HIV ME may predict the
probability of exposure within certain groups, but it cannot deter-
mine exposure or infection of specific individuals who might then
be personally contacted. 
Discussion
Among interviewees and public forum attendees, there was
near unanimous support for HIV ME research. However, the inter-
views make it clear that this support is conditional. Interviewees
expressed concerns about breaches of privacy and how public
interpretation of HIV ME studies could lead to increased anti-gay
sentiment. Some interviewees were careful to specify that the
research should be done as long as proper protections are put in
place. 
Concerns about molecular epidemiology were not immediately
apparent to many of the participants. Some of the interviewees
who did raise potential problems did so only with direct prompting
to do so. Some spoke of worries that others might have, but empha-
sized that they were not personally concerned. Many interviewees
voiced more concerns about risks during the concluding questions
of the interview than they did early on. Only seven interviewees
described, at the outset of the interview, the same issue they iden-
tified as most worrisome at the conclusion. This suggests that inter-
viewees were not immediately able to identify risks they were
most concerned about and had to be walked through potential sce-
narios before they could identify worrisome risks. Of course, by
the end of the interview many responded directly to the privacy
concerns rehearsed by the structure of the interview. Compared to
those who anticipated privacy concerns at the start of the interview,
many more interviewees identified privacy issues as worrisome at
the end of the interview. 
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While over the course of the interviews most subjects were
able to appreciate the risks of HIV ME research, all interviewees
said the benefits of HIV ME research outweighed the risks and that
the research in this area should continue. Similarly, the question-
naire respondents gave mostly positive ratings for benefits and
neutral ratings for risks, suggesting that people responded more to
potential benefits than possible risks. It is difficult to assess the
capacity of the interviewees to fully understand molecular epi-
demiology. Even in the interviews with medical and non-medical
professionals, there were moments that suggested confusion about
the potential of HIV ME. The misunderstandings identified here
were not demonstrated clearly in the majority of interviews, but
other interviewees could have harboured similar but unstated mis-
conceptions. Indeed, some of these misunderstandings only came
to light with the interviewees who were sufficiently sophisticated
to articulate clear questions. Unchallenged assumptions would not
have been so easy to capture. The misunderstandings we have
identified suggest a tendency to either over- or under-estimate the
potential of HIV ME to uncover sensitive information. Those who
fail to understand what is novel about the technique will not appre-
ciate the unique privacy challenges it presents. On the other hand,
those who attribute more accuracy or predictive power to HIV ME
than is possible may become overly worried about unlikely or
impossible scenarios. In either case, these misunderstandings
threaten the possibility of obtaining informed consent.
New and rapidly developing technologies like molecular epi-
demiology are difficult to explain to a broad audience, especially
when the developers and early adopters themselves do not fully
understand the implications of their work. Confusion, misunder-
standings, and blind spots are understandable, but this does not
excuse researchers from the task of explaining the approach and
the unknowns to potential subjects. However, the discussions we
had in the context of these interviews were responsive to each
interviewee, often took significant time, and yet did not always
result in an understanding that could be construed as informed.
This presents a challenge for researchers who want to inform their
subjects but will not have time for such in-depth discussions. This
is further complicated in ME research where the degree of risk and
benefit is not well understood.Limitations
In this article, we focus on questions of informed consent and
risk to research subjects, both traditionally understood as issues in
research ethics. However, studies using HIV ME often aim to
refine or develop new strategies for HIV prevention in the context
of public health. When describing the risks and benefits of HIV
ME to lay persons, we found it difficult to restrict discussion to
research applications only. Our explanation of the technique
depended on illustrating the power of the technique with examples
of potential public health interventions based on HIV ME. While
much of the interview guide focused on HIV ME in a research set-
ting, specific hypotheticals were included involving use of HIV
ME analyses by public health departments and attorneys. In this
paper, we report on responses to questions focused on the research
setting. At the end of the interviews, after discussing both research
and public health contexts, interviewees were specifically asked to
focus on the research context, but it is not possible to know if inter-
viewees were able to maintain this distinction when thinking about
their concerns. Similarly, the questionnaire prompts given to forum
participants were intended to refer to HIV ME carried out by
researchers rather than public health officials, but the question
explicitly asked respondents to weigh the benefits to public health
when considering their answer. Because of these ambiguities, is
not possible to know if forum participants maintained a clear dis-
tinction between HIV ME used in a research setting and possible
use in a public health setting when answering this question. 
Like all qualitative studies, this work can identify a range of
concerns but cannot reliably associate those concerns with large
groups of people. The specific composition of our participant
group must be taken into consideration. This study focuses on the
points of view of potential research subjects and the professionals
who work with them. Most interviewees were already invested in
HIV research and are of particular interest and importance as they
stand to be most affected by HIV ME. As many of the HIV positive
and at risk interviewees were concurrently or had in the past par-
ticipated in medical research related to HIV, they may have been
more likely to discount risks to their privacy compared to others
who hesitate to serve as research subjects. The thoughts and opin-
ions of people unwilling to be subjects obviously could not be cap-
tured and the public acceptance of HIV ME may be less supportive
than what we encountered. 
Likewise, we do not have sufficient data to know if certain
types of responses to HIV ME might be more or less prevalent in
subgroups. We do not have sufficient numbers to state, for exam-
ple, whether women feel differently than men, or MSM have dif-
ferent concerns than injection drug users. Perhaps our work will
inspire future studies on such topics.
The data collected from attendees to the public lecture were
exploratory and cannot be interpreted as reflecting general public
opinion. The group was relatively small and self-selected and had
little incentive to think deeply about their answers. The setting and
the short format of the questionnaire prevented collection of poten-
tially identifying information regarding background and demo-
graphics.
Conclusions
Overall, we found wide support for using molecular epidemi-
ology to study HIV epidemics and transmission, but with concerns
about potential risks to personal privacy and provocation of anti-
gay sentiment. Unfortunately, both support for and concerns about
this approach may be based in part on flawed understandings of
molecular epidemiology. 
In our interviews, only a handful of interviewees understood
the privacy implications after the initial description of HIV ME,
indicating that the risks of HIV ME may be difficult for both lay
and professional individuals to grasp without deep knowledge of
the technique. This raises questions about the sufficiency of stan-
dard informed consent procedures for HIV ME research; if
research subjects and the professionals they work with cannot eas-
ily appreciate the sensitivity of the information generated by HIV
ME, and the risks of inferential disclosure, they cannot be said to
have offered or made an informed choice that protects the interests
of subjects. 
Because of the potential for severe legal and personal conse-
quences, HIV ME dramatizes general shortcomings in our
approach to privacy in public health research. Any study that too
exactly describes individuals from a small group or links such
descriptions to genetic information is vulnerable to the triangula-
tion techniques identified by Gymrek et al.10 Yet there do not
appear to be sufficient guidelines for reporting in studies with
small numbers of participants or studies that link genetic profiles
to sets of identifiable traits. Techniques that allow formal analysis
of privacy risk could play an important role in protecting the sen-
sitive information generated by research, but developing and
deploying these modern methods of privacy protection will require
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stakeholders to decide how much individual privacy might be
risked in the name of public health.
The future of HIV ME as a tool for prevention will depend on
the ability of researchers and public health staff to perform their
work while safeguarding the privacy of their constituents. The dis-
cussion here focused on the research setting, but issues of confi-
dentiality, trust, and public perception of HIV ME will be even
more pressing should the technique be employed by public health
agencies. Researchers, leaders in public health, and legislators will
need to work together to both protect the information they gather
and improve the public’s understanding of these techniques. As
this technique is taken up by public health agencies, it will also be
necessary to develop policies, procedures and best practices to
ensure the privacy of the general public is also sufficiently protect-
ed. This early research on perceptions and attitudes of stakeholders
in HIV ME research points to how crucial and challenging such
work will be. 
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